Changes in T-Cell Subsets in HIV–HCV-coinfected Patients During Pegylated Interferon-Α2a Plus Ribavirin Treatment

Antiviral Therapy - United Kingdom
doi 10.3851/imp1531
Full Text
Abstract

Available in full text

Date
Authors
Publisher

International Medical Press

Related search

Changes in Immune Activation in the T Cell Compartments of HIV HCV Coinfected Patients During PEG IFN RBV Treatment

Retrovirology
VirologyInfectious Diseases
2012English

Decrease in Regulatory T-Cell Function in Chronic Hepatitis C Patients Receiving Pegylated-Interferon Plus Ribavirin

International Journal of Infectious Diseases
MedicineInfectious DiseasesMicrobiology
2017English

Dermatological Manifestations of Pegylated Interferon Alfa2a and Ribavirin Combination Therapy in Chronic HCV Patients

Afro-Egyptian Journal of Infectious and Endemic Diseases
2016English

IL28B Polymorphism Is Not Associated With HCV Protease Diversity in Patients Co-Infected With HIV and HCV Treated With Pegylated Interferon and Ribavirin

Journal of Medical Virology
VirologyInfectious Diseases
2012English

Efficacy of 60 Weeks Treatment of Pegylated Interferon Plus Ribavirin in Patients Whose HCV RNA Tuned Negative by Real-Time PCR Assay at 12 Weeks

Acta Hepatologica Japonica
Hepatology
2010English

Combination Therapy With Pegylated Interferon Plus Ribavirin in the Treatment of Hepatitis C Virus-Related Thrombocytopenia

Current Therapeutic Research
Pharmacology
2005English

Trend of Estimated Glomerular Filtration Rate During Ombistasvir/Paritaprevir/Ritonavir Plus Dasabuvir ± Ribavirin in HIV/HCV Co-Infected Patients

PLoS ONE
Multidisciplinary
2018English

Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4+ T-Cell Counts

Journal of Acquired Immune Deficiency Syndromes
Infectious DiseasesPharmacology
2009English

Rates of HCV Treatment Eligibility Among HCV-Monoinfected and HCV/HIV-Coinfected Patients in Tertiary Care Referral Centers

HIV Clinical Trials
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy